業績一覧の更新

業績一覧への2017年から2019年業績の追加について

業績一覧を更新いたしましたのでご参照ください。今後は最新の業績、研究成果についてタイムリーに公表していこうと考えております。今後ともどうぞよろしくお願いいたします。


業績集ページへのリンク

論文一覧、リンク先について

更新しました論文とその抄録へのリンク先を提示いたします。ご参照ください。


1.
Efficacy and safety of immediate oral intake in patients with mild acute pancreatitis: A randomized controlled trial.
Horibe M, Iwasaki E, Nakagawa A, Matsuzaki J, Minami K, Machida Y, Tamagawa H, Takimoto Y, Ueda M, Katayama T, Kawasaki S, Matsushita M, Seino T, Fukuhara S, Kanai T.Horibe M, et al.Nutrition. 2020 Jan 15;74:110724. doi: 10.1016/j.nut.2020.110724. Online ahead of print.Nutrition. 2020.PMID: 32200266
2.
Giant Mesocaval Shunt Formed by Recurrent Ileal Intussusception.
Takabayashi K, Hosoe N, Ogata H, Kanai T.Takabayashi K, et al.Intern Med. 2020;59(5):747-748. doi: 10.2169/internalmedicine.3874- 19. Epub 2020 Mar 1.Intern Med. 2020.PMID: 32115521Free PMC article.No abstract available.
3.
5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis.
Mizuno S, Ono K, Mikami Y, Naganuma M, Fukuda T, Minami K, Masaoka T, Terada S, Yoshida T, Saigusa K, Hirahara N, Miyata H, Suda W, Hattori M, Kanai T.Mizuno S, et al.Intest Res. 2020 Jan;18(1):69-78. doi: 10.5217/ir.2019.00084. Epub 2020 Jan 30.Intest Res. 2020.PMID: 32013315Free PMC article.
4.
Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn's disease in Japanese and Korean patients: the OPERA study.
Saruta M, Park DI, Kim YH, Yang SK, Jang BI, Cheon JH, Im JP, Kanai T, Katsuno T, Ishiguro Y, Nagaoka M, Isogawa N, Li Y, Banerjee A, Ahmad A, Hassan-Zahraee M, Clare R, Gorelick KJ, Cataldi F, Watanabe M, Hibi T.Saruta M, et al.Intest Res. 2020 Jan;18(1):45-55. doi: 10.5217/ir.2019.00039. Epub 2020 Jan 30.Intest Res. 2020.PMID: 32013314Free PMC article.
5.
Endoscopic removal of foreign bodies: A retrospective study in Japan.
Limpias Kamiya KJ, Hosoe N, Takabayashi K, Hayashi Y, Sun X, Miyanaga R, Fukuhara K, Fukuhara S, Naganuma M, Nakayama A, Kato M, Maehata T, Nakamura R, Ueno K, Sasaki J, Kitagawa Y, Yahagi N, Ogata H, Kanai T.Limpias Kamiya KJ, et al.World J Gastrointest Endosc. 2020 Jan 16;12(1):33-41. doi: 10.4253/wjge.v12.i1.33.World J Gastrointest Endosc. 2020.PMID: 31942232Free PMC article.
6.
Transient hypotension during endoscopic resection of gangliocytic paraganglioma with ampullary involvement.
Katayama T, Iwasaki E, Minami K, Fukuhara S, Kanai T.Katayama T, et al.VideoGIE. 2019 Oct 25;5(1):26-28. doi: 10.1016/j.vgie.2019.09.007. eCollection 2020 Jan.VideoGIE. 2019.PMID: 31922078Free PMC article.
7.
[The Relationship between Gut Microbiome, Immune System, and Cancer].
Ichikawa M, Sujino T, Kanai T.Ichikawa M, et al.Gan To Kagaku Ryoho. 2019 Dec;46(12):1807-1813.Gan To Kagaku Ryoho. 2019.PMID: 31879393Japanese.
8.
Somatic inflammatory gene mutations in human ulcerative colitis epithelium.
Nanki K, Fujii M, Shimokawa M, Matano M, Nishikori S, Date S, Takano A, Toshimitsu K, Ohta Y, Takahashi S, Sugimoto S, Ishimaru K, Kawasaki K, Nagai Y, Ishii R, Yoshida K, Sasaki N, Hibi T, Ishihara S, Kanai T, Sato T.Nanki K, et al.Nature. 2020 Jan;577(7789):254-259. doi: 10.1038/s41586-019-1844-5. Epub 2019 Dec 18.Nature. 2020.PMID: 31853059
9.
Effects of vedolizumab in Japanese patients with Crohn's disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses.
Watanabe K, Motoya S, Ogata H, Kanai T, Matsui T, Suzuki Y, Shikamura M, Sugiura K, Oda K, Hori T, Araki T, Watanabe M, Hibi T.Watanabe K, et al.J Gastroenterol. 2020 Mar;55(3):291-306. doi: 10.1007/s00535-019-01647-w. Epub 2019 Dec 13.J Gastroenterol. 2020.PMID: 31836930Free PMC article.
10.
Predictors of technical difficulty with duodenal ESD.
Kato M, Sasaki M, Mizutani M, Tsutsumi K, Kiguchi Y, Akimoto T, Mutaguchi M, Nakayama A, Takabayashi K, Fujimoto A, Ochiai Y, Maehata T, Kanai T, Yahagi N.Kato M, et al.Endosc Int Open. 2019 Dec;7(12):E1755-E1760. doi: 10.1055/a-0967-4744. Epub 2019 Dec 10.Endosc Int Open. 2019.PMID: 31828213Free PMC article.
11.
Efficacy of Novel Ultrathin Single-Balloon Enteroscopy for Crohn's Disease: A Propensity Score-Matched Study.
Takabayashi K, Hosoe N, Kato M, Hayashi Y, Miyanaga R, Nanki K, Fukuhara K, Mikami Y, Mizuno S, Sujino T, Mutaguchi M, Naganuma M, Yahagi N, Ogata H, Kanai T.Takabayashi K, et al.Gut Liver. 2019 Dec 12. doi: 10.5009/gnl19228. Online ahead of print.Gut Liver. 2019.PMID: 31818049
12.
Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial.
Naganuma M, Yokoyama Y, Motoya S, Watanabe K, Sawada K, Hirai F, Yamamoto T, Hanai H, Omori T, Kanai T, Hibi T; CAPTAIN study Group.Naganuma M, et al.J Gastroenterol. 2020 Apr;55(4):390-400. doi: 10.1007/s00535-019-01651-0. Epub 2019 Dec 6.J Gastroenterol. 2020.PMID: 31811562
13.
A long (7 cm) prophylactic pancreatic stent decreases incidence of post-endoscopic papillectomy pancreatitis: a retrospective study.
Minami K, Iwasaki E, Kawasaki S, Fukuhara S, Seino T, Katayama T, Takimoto Y, Tamagawa H, Machida Y, Horibe M, Kitago M, Ogata H, Kanai T.Minami K, et al.Endosc Int Open. 2019 Dec;7(12):E1663-E1670. doi: 10.1055/a-1010-5581. Epub 2019 Nov 25.Endosc Int Open. 2019.PMID: 31788550Free PMC article.
14.
A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure-Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial).
Suzuki T, Sukawa Y, Imamura CK, Masuishi T, Satake H, Kumekawa Y, Funakoshi S, Kotaka M, Horie Y, Kawai S, Okuda H, Terazawa T, Kondoh C, Kato K, Yoshimura K, Ishikawa H, Hamamoto Y, Boku N, Takaishi H, Kanai T.Suzuki T, et al.Clin Colorectal Cancer. 2020 Mar;19(1):13-21.e3. doi: 10.1016/j.clcc.2019.10.004. Epub 2019 Oct 23.Clin Colorectal Cancer. 2020.PMID: 31732439
15.
Previous Helicobacter pylori infection-induced atrophic gastritis: A distinct disease entity in an understudied population without a history of eradication.
Kishikawa H, Ojiro K, Nakamura K, Katayama T, Arahata K, Takarabe S, Miura S, Kanai T, Nishida J.Kishikawa H, et al.Helicobacter. 2020 Feb;25(1):e12669. doi: 10.1111/hel.12669. Epub 2019 Nov 3.Helicobacter. 2020.PMID: 31680399Free PMC article.Review.
16.
Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma.
Kawasaki K, Fujii M, Sugimoto S, Ishikawa K, Matano M, Ohta Y, Toshimitsu K, Takahashi S, Hosoe N, Sekine S, Kanai T, Sato T.Kawasaki K, et al.Gastroenterology. 2020 Feb;158(3):638-651.e8. doi: 10.1053/j.gastro.2019.10.009. Epub 2019 Oct 14.Gastroenterology. 2020.PMID: 31622618
17.
Clinical and Endoscopic Characteristics of Pyogenic Granuloma in the Small Intestine: A Case Series with Literature Review.
Hayashi Y, Hosoe N, Takabayashi K, Kamiya KJL, Mutaguchi M, Miyanaga R, Hirata K, Fukuhara S, Mikami Y, Sujino T, Masugi Y, Naganuma M, Ogata H, Kanai T.Hayashi Y, et al.Intern Med. 2020 Feb 15;59(4):501-505. doi: 10.2169/internalmedicine.3745- 19. Epub 2019 Oct 15.Intern Med. 2020.PMID: 31611535Free PMC article.
18.
Management of perforation related to endoscopic submucosal dissection for superficial duodenal epithelial tumors.
Fukuhara S, Kato M, Iwasaki E, Sasaki M, Tsutsumi K, Kiguchi Y, Akimoto T, Takatori Y, Nakayama A, Maehata T, Minami K, Ogata H, Kanai T, Yahagi N.Fukuhara S, et al.Gastrointest Endosc. 2020 May;91(5):1129-1137. doi: 10.1016/j.gie.2019.09.024. Epub 2019 Sep 26.Gastrointest Endosc. 2020.PMID: 31563595
19.
How I do it: Endoscopic diagnosis for superficial non-ampullary duodenal epithelial tumors.
Nakayama A, Kato M, Takatori Y, Shimoda M, Mizutani M, Tsutsumi K, Kiguchi Y, Akimoto T, Sasaki M, Mutaguchi M, Takabayashi K, Maehata T, Ochiai Y, Kanai T, Yahagi N.Nakayama A, et al.Dig Endosc. 2020 Mar;32(3):417-424. doi: 10.1111/den.13538. Epub 2019 Oct 31.Dig Endosc. 2020.PMID: 31545536
20.
Reply.
Naganuma M, Kanai T.Naganuma M, et al.Clin Gastroenterol Hepatol. 2019 Sep 18:S1542-3565(19)31020-1. doi: 10.1016/j.cgh.2019.09.015. Online ahead of print.Clin Gastroenterol Hepatol. 2019.PMID: 31541707No abstract available.
21.
Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study.
Naganuma M, Sugimoto S, Fukuda T, Mitsuyama K, Kobayashi T, Yoshimura N, Ohi H, Tanaka S, Andoh A, Ohmiya N, Saigusa K, Yamamoto T, Morohoshi Y, Ichikawa H, Matsuoka K, Hisamatsu T, Watanabe K, Mizuno S, Abe T, Suzuki Y, Kanai T; INDIGO Study Group.Naganuma M, et al.J Gastroenterol. 2020 Feb;55(2):169-180. doi: 10.1007/s00535-019-01625-2. Epub 2019 Sep 16.J Gastroenterol. 2020.PMID: 31529220
22.
Feasibility study comparing underwater endoscopic mucosal resection and conventional endoscopic mucosal resection for superficial non-ampullary duodenal epithelial tumor < 20 mm.
Kiguchi Y, Kato M, Nakayama A, Sasaki M, Mizutani M, Tsutsumi K, Akimoto T, Takatori Y, Mutaguchi M, Takabayashi K, Ochiai Y, Maehata T, Kanai T, Yahagi N.Kiguchi Y, et al.Dig Endosc. 2019 Sep 9. doi: 10.1111/den.13524. Online ahead of print.Dig Endosc. 2019.PMID: 31498932
23.
The Effect of an Invasive Strategy for Treating Pancreatic Necrosis on Mortality: a Retrospective Multicenter Cohort Study.
Minami K, Horibe M, Sanui M, Sasaki M, Iwasaki E, Sawano H, Goto T, Ikeura T, Takeda T, Oda T, Yasuda H, Ogura Y, Miyazaki D, Kitamura K, Chiba N, Ozaki T, Yamashita T, Koinuma T, Oshima T, Yamamoto T, Hirota M, Tokuhira N, Azumi Y, Nagata K, Takeda K, Furuya T, Lefor AK, Mayumi T, Kanai T.Minami K, et al.J Gastrointest Surg. 2019 Aug 19. doi: 10.1007/s11605-019-04333-7. Online ahead of print.J Gastrointest Surg. 2019.PMID: 31428962
24.
Significance of Conducting 2 Types of Fecal Tests in Patients With Ulcerative Colitis.
Naganuma M, Kobayashi T, Nasuno M, Motoya S, Kato S, Matsuoka K, Hokari R, Watanabe C, Sakamoto H, Yamamoto H, Sasaki M, Watanabe K, Iijima H, Endo Y, Ichikawa H, Ozeki K, Tanida S, Ueno N, Fujiya M, Sako M, Takeuchi K, Sugimoto S, Abe T, Hibi T, Suzuki Y, Kanai T.Naganuma M, et al.Clin Gastroenterol Hepatol. 2020 May;18(5):1102-1111.e5. doi: 10.1016/j.cgh.2019.07.054. Epub 2019 Aug 5.Clin Gastroenterol Hepatol. 2020.PMID: 31394288
25.
10-Year Trends in Helicobacter pylori Eradication Rates by Sitafloxacin-Based Third-Line Rescue Therapy.
Mori H, Suzuki H, Matsuzaki J, Masaoka T, Kanai T.Mori H, et al.Digestion. 2019 Aug 6:1-7. doi: 10.1159/000501610. Online ahead of print.Digestion. 2019.PMID: 31387107
26.
Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam.
Naganuma M, Hirai F, Kobayashi K, Watanabe K, Takeuchi K, Aoyama N, Nozawa H, Motoya S, Ohmori T, Harada A, Nagai Y, Abe T, Yamada Y, Inagaki K, Shimizu N, Kanai T, Watanabe M; ESCORT study Group.Naganuma M, et al.PLoS One. 2019 Aug 5;14(8):e0220413. doi: 10.1371/journal.pone.0220413. eCollection 2019.PLoS One. 2019.PMID: 31381615Free PMC article.Clinical Trial.
27.
Pancreatic fat content may increase the risk of imaging progression in low-risk branch duct intraductal papillary mucinous neoplasm.
Kashiwagi K, Minami K, Seino T, Hirata K, Iwasaki E, Inoue N, Iwao Y, Kanai T.Kashiwagi K, et al.J Dig Dis. 2019 Oct;20(10):557-562. doi: 10.1111/1751-2980.12801. Epub 2019 Aug 30.J Dig Dis. 2019.PMID: 31322828
28.
[Current knowledge of irritable bowel syndrome -treatment].
Masaoka T, Kanai T.Masaoka T, et al.Nihon Shokakibyo Gakkai Zasshi. 2019;116(7):570-575. doi: 10.11405/nisshoshi.116.570.Nih on Shokakibyo Gakkai Zasshi. 2019.PMID: 31292318Japanese.No abstract available.
29.
Intramucosal poorly differentiated and signet-ring cell components in patients with ulcerative colitis-associated high-grade dysplasia.
Sugimoto S, Shimoda M, Iwao Y, Mutaguchi M, Nanki K, Mizuno S, Kameyama K, Ogata H, Naganuma M, Kanai T.Sugimoto S, et al.Dig Endosc. 2019 Nov;31(6):706-711. doi: 10.1111/den.13482. Epub 2019 Aug 22.Dig Endosc. 2019.PMID: 31278777
30.
Plasmacytoid dendritic cells protect against immune-mediated acute liver injury via IL-35.
Koda Y, Nakamoto N, Chu PS, Ugamura A, Mikami Y, Teratani T, Tsujikawa H, Shiba S, Taniki N, Sujino T, Miyamoto K, Suzuki T, Yamaguchi A, Morikawa R, Sato K, Sakamoto M, Yoshimoto T, Kanai T.Koda Y, et al.J Clin Invest. 2019 Jul 2;129(8):3201-3213. doi: 10.1172/JCI125863. eCollection 2019 Jul 2.J Clin Invest. 2019.PMID: 31264967Free PMC article.
31.
Electric Endocut and Autocut Resection for Endoscopic Papillectomy: A Systematic Review.
Minami K, Iwasaki E, Fukuhara S, Horibe M, Seino T, Kawasaki S, Katayama T, Takimoto Y, Tamagawa H, Machida Y, Kanai T, Itoi T.Minami K, et al.Intern Med. 2019 Oct 1;58(19):2767-2772. doi: 10.2169/internalmedicine.2720- 19. Epub 2019 Jun 27.Intern Med. 2019.PMID: 31243201Free PMC article.
32.
Development of an Indigo Naturalis Suppository for Topical Induction Therapy in Patients with Ulcerative Colitis.
Yoshimatsu Y, Naganuma M, Sugimoto S, Tanemoto S, Umeda S, Fukuda T, Nomura E, Yoshida K, Ono K, Mutaguchi M, Nanki K, Mizuno S, Mikami Y, Fukuhara K, Sujino T, Takabayashi K, Ogata H, Iwao Y, Kanai T.Yoshimatsu Y, et al.Digestion. 2019 Jun 25:1-7. doi: 10.1159/000501152. Online ahead of print.Digestion. 2019.PMID: 31238326
33.
Impact of electrical pulse cut mode during endoscopic papillectomy: Pilot randomized clinical trial.
Iwasaki E, Minami K, Itoi T, Yamamoto K, Tsuji S, Sofuni A, Tsuchiya T, Tanaka R, Tonozuka R, Machida Y, Takimoto Y, Tamagawa H, Katayama T, Kawasaki S, Seino T, Horibe M, Fukuhara S, Kitago M, Ogata H, Kanai T.Iwasaki E, et al.Dig Endosc. 2020 Jan;32(1):127-135. doi: 10.1111/den.13468. Epub 2019 Oct 3.Dig Endosc. 2020.PMID: 31222794
34.
Erratum: Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis.
Shinzaki S, Matsuoka K, Iijima H, Mizuno S, Serada S, Fujimoto M, Arai N, Koyama N, Morii E, Watanabe M, Hibi T, Kanai T, Takehara T, Naka T.Shinzaki S, et al.J Crohns Colitis. 2019 Dec 10;13(12):1590. doi: 10.1093/ecco-jcc/jjz100.J Crohns Colitis. 2019.PMID: 31222277Free PMC article.No abstract available.
35.
Endoscopic characteristics of small intestinal malignant tumors observed by balloon-assisted enteroscopy.
Horie T, Hosoe N, Takabayashi K, Hayashi Y, Kamiya KJL, Miyanaga R, Mizuno S, Fukuhara K, Fukuhara S, Naganuma M, Shimoda M, Ogata H, Kanai T.Horie T, et al.World J Gastrointest Endosc. 2019 May 16;11(5):373-382. doi: 10.4253/wjge.v11.i5.373.World J Gastrointest Endosc. 2019.PMID: 31205598Free PMC article.
36.
Difference in the clinical characteristic and prognosis of colitis-associated cancer and sporadic neoplasia in ulcerative colitis patients.
Mutaguchi M, Naganuma M, Sugimoto S, Fukuda T, Nanki K, Mizuno S, Hosoe N, Shimoda M, Ogata H, Iwao Y, Kanai T.Mutaguchi M, et al.Dig Liver Dis. 2019 Sep;51(9):1257-1264. doi: 10.1016/j.dld.2019.05.003.Dig Liver Dis. 2019.PMID: 31151895
37.
Late-onset visceral varicella-zoster virus infection presented as acute liver failure after allogeneic hematopoietic stem cell transplantation.
Kikuchi T, Arai M, Koda Y, Kato J, Shimizu T, Katano H, Fujii-Nishimura Y, Sakamoto M, Ebinuma H, Nakamoto N, Kanai T, Okamoto S, Mori T.Kikuchi T, et al.Transpl Infect Dis. 2019 Aug;21(4):e13121. doi: 10.1111/tid.13121. Epub 2019 Jun 14.Transpl Infect Dis. 2019.PMID: 31127967
38.
Neutrophil-activating Protein Polymorphism of Helicobacter pylori Determines the Host Risk of Dyspepsia.
Matsuzaki J, Tsugawa H, Kashiwazaki Y, Mori H, Yamamoto Y, Kameyama H, Masaoka T, Kanai T, Suzuki H.Matsuzaki J, et al.Cell Mol Gastroenterol Hepatol. 2019;8(2):295-297.e6. doi: 10.1016/j.jcmgh.2019.05.004. Epub 2019 May 18.Cell Mol Gastroenterol Hepatol. 2019.PMID: 31108232Free PMC article.No abstract available.
39.
Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide survey.
Naganuma M, Sugimoto S, Suzuki H, Matsuno Y, Araki T, Shimizu H, Hayashi R, Fukuda T, Nakamoto N, Iijima H, Nakamura S, Kataoka M, Tamura Y, Tatsumi K, Hibi T, Suzuki Y, Kanai T; INDIGO survey Group.Naganuma M, et al.J Gastroenterol. 2019 Oct;54(10):891-896. doi: 10.1007/s00535-019-01591-9. Epub 2019 May 17.J Gastroenterol. 2019.PMID: 31102012
40.
Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis.
Ji F, Yeo YH, Wei MT, Ogawa E, Enomoto M, Lee DH, Iio E, Lubel J, Wang W, Wei B, Ide T, Preda CM, Conti F, Minami T, Bielen R, Sezaki H, Barone M, Kolly P, Chu PS, Virlogeux V, Eurich D, Henry L, Bass MB, Kanai T, Dang S, Li Z, Dufour JF, Zoulim F, Andreone P, Cheung RC, Tanaka Y, Furusyo N, Toyoda H, Tamori A, Nguyen MH.Ji F, et al.J Hepatol. 2019 Sep;71(3):473-485. doi: 10.1016/j.jhep.2019.04.017. Epub 2019 May 13.J Hepatol. 2019.PMID: 31096005
41.
Clinical and endoscopic findings to assist the early detection of duodenal adenoma and adenocarcinoma.
Matsuzaki J, Suzuki H, Shimoda M, Mori H, Fukuhara S, Miyoshi S, Masaoka T, Iwao Y, Kanai Y, Kanai T.Matsuzaki J, et al.United European Gastroenterol J. 2019 Mar;7(2):250-260. doi: 10.1177/2050640618817689. Epub 2018 Dec 3.United European Gastroenterol J. 2019.PMID: 31080610Free PMC article.
42.
Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine.
Akiyama S, Matsuoka K, Fukuda K, Hamada S, Shimizu M, Nanki K, Mizuno S, Kiyohara H, Arai M, Sugimoto S, Iwao Y, Ogata H, Hisamatsu T, Naganuma M, Motobayashi M, Suzuki K, Takenaka K, Fujii T, Saito E, Nagahori M, Ohtsuka K, Mochizuki M, Watanabe M, Hashiguchi M, Kanai T.Akiyama S, et al.J Gastroenterol Hepatol. 2019 Oct;34(10):1751-1757. doi: 10.1111/jgh.14693. Epub 2019 Jun 26.J Gastroenterol Hepatol. 2019.PMID: 31045285
43.
Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2).
Hisamatsu T, Kato S, Kunisaki R, Matsuura M, Nagahori M, Motoya S, Esaki M, Fukata N, Inoue S, Sugaya T, Sakuraba H, Hirai F, Watanabe K, Kanai T, Naganuma M, Nakase H, Suzuki Y, Watanabe M, Hibi T, Nojima M, Matsumoto T; DIAMOND2 Study Group.Hisamatsu T, et al.J Gastroenterol. 2019 Oct;54(10):860-870. doi: 10.1007/s00535-019-01582-w. Epub 2019 Apr 30.J Gastroenterol. 2019.PMID: 31041545
44.
Negative effect of fatty liver on visualization of pancreatic cystic lesions at screening transabdominal ultrasonography.
Kashiwagi K, Seino T, Makino K, Shimizu-Hirota R, Takayama M, Yoshida T, Iwasaki E, Sugino Y, Inoue N, Iwao Y, Kanai T.Kashiwagi K, et al.J Eval Clin Pract. 2020 Feb;26(1):256-261. doi: 10.1111/jep.13138. Epub 2019 Apr 22.J Eval Clin Pract. 2020.PMID: 31012194
45.
Pharmacological effects of TAK-828F: an orally available RORγt inverse agonist, in mouse colitis model and human blood cells of inflammatory bowel disease.
Igaki K, Nakamura Y, Tanaka M, Mizuno S, Yoshimatsu Y, Komoike Y, Uga K, Shibata A, Imaichi H, Takayuki S, Ishimura Y, Yamasaki M, Kanai T, Tsukimi Y, Tsuchimori N.Igaki K, et al.Inflamm Res. 2019 Jun;68(6):493-509. doi: 10.1007/s00011-019-01234-y. Epub 2019 Apr 10.Inflamm Res. 2019.PMID: 30972425
46.
Novel mainstream capnometer system is safe and feasible even under CO2 insufflation during ERCP-related procedure: a pilot study.
Takimoto Y, Iwasaki E, Masaoka T, Fukuhara S, Kawasaki S, Seino T, Katayama T, Minami K, Tamagawa H, Machida Y, Ogata H, Kanai T.Takimoto Y, et al.BMJ Open Gastroenterol. 2019 Feb 28;6(1):e000266. doi: 10.1136/bmjgast-2018-000266. eCollection 2019.BMJ Open Gastroenterol. 2019.PMID: 30899539Free PMC article.
47.
Epigenetic regulation of T helper cells and intestinal pathogenicity.
Hagihara Y, Yoshimatsu Y, Mikami Y, Takada Y, Mizuno S, Kanai T.Hagihara Y, et al.Semin Immunopathol. 2019 May;41(3):379-399. doi: 10.1007/s00281-019-00732-9. Epub 2019 Mar 19.Semin Immunopathol. 2019.PMID: 30891628Review.
48.
Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study.
Motoya S, Watanabe K, Ogata H, Kanai T, Matsui T, Suzuki Y, Shikamura M, Sugiura K, Oda K, Hori T, Araki T, Watanabe M, Hibi T.Motoya S, et al.PLoS One. 2019 Feb 26;14(2):e0212989. doi: 10.1371/journal.pone.0212989. eCollection 2019.PLoS One. 2019.PMID: 30807613Free PMC article.Clinical Trial.
49.
Concerns and Side Effects of Azathioprine During Adalimumab Induction and Maintenance Therapy for Japanese Patients With Crohn's Disease: A Subanalysis of a Prospective Randomised Clinical Trial [DIAMOND Study].
Hisamatsu T, Matsumoto T, Watanabe K, Nakase H, Motoya S, Yoshimura N, Ishida T, Kato S, Nakagawa T, Esaki M, Nagahori M, Matsui T, Naito Y, Kanai T, Suzuki Y, Nojima M, Watanabe M, Hibi T; DIAMOND study group.Hisamatsu T, et al.J Crohns Colitis. 2019 Sep 19;13(9):1097-1104. doi: 10.1093/ecco-jcc/jjz030.J Crohns Colitis. 2019.PMID: 30753377Clinical Trial.
50.
Current new challenges in the management of ulcerative colitis.
Fukuda T, Naganuma M, Kanai T.Fukuda T, et al.Intest Res. 2019 Jan;17(1):36-44. doi: 10.5217/ir.2018.00126. Epub 2019 Jan 25.Intest Res. 2019.PMID: 30678445Free PMC article.
51.
Capsule endoscopy for small-intestinal disorders: Current status.
Hosoe N, Takabayashi K, Ogata H, Kanai T.Hosoe N, et al.Dig Endosc. 2019 Sep;31(5):498-507. doi: 10.1111/den.13346. Epub 2019 Feb 10.Dig Endosc. 2019.PMID: 30656743Review.
52.
Early administration of systemic chemotherapy should be considered for scirrhous gastric cancer: A case report.
Aoki Y, Hamamoto Y, Ugamura A, Togasaki K, Suzuki T, Kawasaki K, Hirata K, Kasuga A, Sukawa Y, Kanai T, Takaishi H.Aoki Y, et al.Mol Clin Oncol. 2019 Jan;10(1):113-117. doi: 10.3892/mco.2018.1767. Epub 2018 Nov 16.Mol Clin Oncol. 2019.PMID: 30655985Free PMC article.
53.
Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis.
Nakamoto N, Sasaki N, Aoki R, Miyamoto K, Suda W, Teratani T, Suzuki T, Koda Y, Chu PS, Taniki N, Yamaguchi A, Kanamori M, Kamada N, Hattori M, Ashida H, Sakamoto M, Atarashi K, Narushima S, Yoshimura A, Honda K, Sato T, Kanai T.Nakamoto N, et al.Nat Microbiol. 2019 Mar;4(3):492-503. doi: 10.1038/s41564-018-0333-1. Epub 2019 Jan 14.Nat Microbiol. 2019.PMID: 30643240
54.
Colonic diverticular bleeding and predictors of the length of hospitalization: An observational study.
Wada M, Nishizawa T, Kato M, Hirai Y, Kinoshita S, Mori H, Nakazato Y, Fujimoto A, Kikuchi M, Uraoka T, Kanai T.Wada M, et al.J Gastroenterol Hepatol. 2019 Aug;34(8):1351-1356. doi: 10.1111/jgh.14603. Epub 2019 Jan 29.J Gastroenterol Hepatol. 2019.PMID: 30636058Clinical Trial.
55.
Clinical efficacy of immune checkpoint inhibitors in the treatment of unresectable advanced or recurrent gastric cancer: an evidence-based review of therapies.
Togasaki K, Sukawa Y, Kanai T, Takaishi H.Togasaki K, et al.Onco Targets Ther. 2018 Nov 21;11:8239-8250. doi: 10.2147/OTT.S152514. eCollection 2018.Onco Targets Ther. 2018.PMID: 30538493Free PMC article.Review.
56.
Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells.
Kiyohara H, Sujino T, Teratani T, Miyamoto K, Arai MM, Nomura E, Harada Y, Aoki R, Koda Y, Mikami Y, Mizuno S, Naganuma M, Hisamatsu T, Kanai T.Kiyohara H, et al.Cell Mol Gastroenterol Hepatol. 2018 Sep 25;7(1):135-156. doi: 10.1016/j.jcmgh.2018.09.010. eCollection 2019.Cell Mol Gastroenterol Hepatol. 2018.PMID: 30510995Free PMC article.
57.
Pethidine dose and female sex as risk factors for nausea after esophagogastroduodenoscopy.
Nishizawa T, Suzuki H, Arita M, Kataoka Y, Fukagawa K, Ohki D, Hata K, Uraoka T, Kanai T, Yahagi N, Toyoshima O.Nishizawa T, et al.J Clin Biochem Nutr. 2018 Nov;63(3):230-232. doi: 10.3164/jcbn.18-5. Epub 2018 Jun 20.J Clin Biochem Nutr. 2018.PMID: 30487674Free PMC article.
58.
Risk factors associated with pseudoaldosteronism in patients with chronic hepatitis: A retrospective cohort study.
Komatsu A, Yoshino T, Suzuki T, Nakamura T, Kanai T, Watanabe K.Komatsu A, et al.Basic Clin Pharmacol Toxicol. 2019 May;124(5):607-614. doi: 10.1111/bcpt.13178. Epub 2018 Dec 18.Basic Clin Pharmacol Toxicol. 2019.PMID: 30471199
59.
How Can We Assess "Complete Healing" Beyond Endoscopic Remission?
Fukuda T, Naganuma M, Kanai T.Fukuda T, et al.Inflamm Bowel Dis. 2019 May 4;25(6):e68. doi: 10.1093/ibd/izy356.Inflamm Bowel Dis. 2019.PMID: 30462236No abstract available.
60.
Methotrexate-associated Lymphoproliferative Disorder of the Stomach Presumed to Be Mucosa-associated Lymphoid Tissue Lymphoma.
Ishigaki S, Masaoka T, Kameyama H, Kawaida M, Kameyama K, Mori T, Kanai T.Ishigaki S, et al.Intern Med. 2018;57(22):3249-3254. doi: 10.2169/internalmedicine.0737- 18. Epub 2018 Nov 15.Intern Med. 2018.PMID: 30429434Free PMC article.
61.
Liver Fibrosis Markers Improve Prediction of Outcome in Non-Acetaminophen-Associated Acute Liver Failure.
Ugamura A, Chu PS, Nakamoto N, Taniki N, Ojiro K, Hibi T, Shinoda M, Obara H, Masugi Y, Yamaguchi A, Shiba S, Morikawa R, Usui S, Ebinuma H, Kitagawa Y, Saito H, Kanai T.Ugamura A, et al.Hepatol Commun. 2018 Sep 21;2(11):1331-1343. doi: 10.1002/hep4.1233. eCollection 2018 Nov.Hepatol Commun. 2018.PMID: 30411080Free PMC article.
62.
Successful EUS-guided antegrade stenting for malignant severe biliary obstruction combined with a newly developed plastic stent.
Minami K, Iwasaki E, Itoi T, Fukuhara S, Horibe M, Seino T, Kawasaki S, Katayama T, Takimoto Y, Tamagawa H, Machida Y, Hamamoto Y, Ogata H, Kanai T.Minami K, et al.Endosc Int Open. 2018 Nov;6(11):E1336-E1339. doi: 10.1055/a-0719-4861. Epub 2018 Nov 7.Endosc Int Open. 2018.PMID: 30410954Free PMC article.
63.
A male Korean who was diagnosed with chronic enteropathy associated with SLCO2A1 (CEAS): case report with literature review.
Sun X, Hosoe N, Miyanaga R, Kimura K, Mizuno S, Takabayashi K, Naganuma M, Niizeki H, Seki A, Ogata H, Kanai T.Sun X, et al.BMJ Open Gastroenterol. 2018 Oct 23;5(1):e000223. doi: 10.1136/bmjgast-2018-000223. eCollection 2018.BMJ Open Gastroenterol. 2018.PMID: 30397504Free PMC article.
64.
Inhibiting xCT Improves 5-Fluorouracil Resistance of Gastric Cancer Induced by CD44 Variant 9 Expression.
Miyoshi S, Tsugawa H, Matsuzaki J, Hirata K, Mori H, Saya H, Kanai T, Suzuki H.Miyoshi S, et al.Anticancer Res. 2018 Nov;38(11):6163-6170. doi: 10.21873/anticanres.12969.Anti cancer Res. 2018.PMID: 30396933
65.
Pathophysiology of Potassium-competitive Acid Blocker-refractory Gastroesophageal Reflux and the Potential of Potassium-competitive Acid Blocker Test.
Masaoka T, Kameyama H, Yamane T, Yamamoto Y, Takeuchi H, Suzuki H, Kitagawa Y, Kanai T.Masaoka T, et al.J Neurogastroenterol Motil. 2018 Oct 1;24(4):577-583. doi: 10.5056/jnm18036.J Neurogastroenterol Motil. 2018.PMID: 30347936Free PMC article.
66.
Insertability comparison of passive bending single-balloon prototype versus standard single-balloon enteroscopy: a multicenter randomized non-blinded trial.
Hosoe N, Ohtsuka K, Endo Y, Naganuma M, Ogata N, Kuroki Y, Sasanuma S, Takabayashi K, Kudo SE, Takahashi H, Ogata H, Kanai T.Hosoe N, et al.Endosc Int Open. 2018 Oct;6(10):E1184-E1189. doi: 10.1055/a-0650-4168. Epub 2018 Oct 8.Endosc Int Open. 2018.PMID: 30302375Free PMC article.
67.
5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis.
Miyoshi J, Matsuoka K, Yoshida A, Naganuma M, Hisamatsu T, Yajima T, Inoue N, Okamoto S, Iwao Y, Ogata H, Ueno F, Hibi T, Kanai T.Miyoshi J, et al.Intest Res. 2018 Oct;16(4):635-640. doi: 10.5217/ir.2018.00015. Epub 2018 Oct 10.Intest Res. 2018.PMID: 30301334Free PMC article.
68.
Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn's disease.
Matsuoka K, Hamada S, Shimizu M, Nanki K, Mizuno S, Kiyohara H, Arai M, Sugimoto S, Iwao Y, Ogata H, Hisamatsu T, Naganuma M, Kanai T, Mochizuki M, Hashiguchi M.Matsuoka K, et al.PLoS One. 2018 Oct 4;13(10):e0204632. doi: 10.1371/journal.pone.0204632. eCollection 2018.PLoS One. 2018.PMID: 30286108Free PMC article.
69.
Efficacy of Therapeutic Intervention for Patients With an Ulcerative Colitis Mayo Endoscopic Score of 1.
Fukuda T, Naganuma M, Sugimoto S, Ono K, Nanki K, Mizuno S, Kimura K, Mutaguchi M, Nakazato Y, Takabayashi K, Inoue N, Ogata H, Iwao Y, Kanai T.Fukuda T, et al.Inflamm Bowel Dis. 2019 Mar 14;25(4):782-788. doi: 10.1093/ibd/izy300.Inflamm Bowel Dis. 2019.PMID: 30265308
70.
Management of challenging immune-related gastrointestinal adverse events associated with immune checkpoint inhibitors.
Hamamoto Y, Shin N, Hoshino T, Kanai T.Hamamoto Y, et al.Future Oncol. 2018 Dec;14(30):3187-3198. doi: 10.2217/fon-2018-0509. Epub 2018 Sep 6.Future Oncol. 2018.PMID: 30188189Review.
71.
Correction: Clinical utility of novel ultrathin single-balloon enteroscopy: a feasibility study.
Takabayashi K, Hosoe N, Miyanaga R, Fukuhara S, Kimura K, Mizuno S, Naganuma M, Yahagi N, Ogata H, Kanai T.Takabayashi K, et al.Endoscopy. 2019 May;51(5):C2. doi: 10.1055/a-0676-4553. Epub 2018 Sep 5.Endoscopy. 2019.PMID: 30184605No abstract available.
72.
Innate lymphoid cells in organ fibrosis.
Mikami Y, Takada Y, Hagihara Y, Kanai T.Mikami Y, et al.Cytokine Growth Factor Rev. 2018 Aug;42:27-36. doi: 10.1016/j.cytogfr.2018.07.002. Epub 2018 Jul 30.Cytokine Growth Factor Rev. 2018.PMID: 30104153Review.
73.
Divergent Routes toward Wnt and R-spondin Niche Independency during Human Gastric Carcinogenesis.
Nanki K, Toshimitsu K, Takano A, Fujii M, Shimokawa M, Ohta Y, Matano M, Seino T, Nishikori S, Ishikawa K, Kawasaki K, Togasaki K, Takahashi S, Sukawa Y, Ishida H, Sugimoto S, Kawakubo H, Kim J, Kitagawa Y, Sekine S, Koo BK, Kanai T, Sato T.Nanki K, et al.Cell. 2018 Aug 9;174(4):856-869.e17. doi: 10.1016/j.cell.2018.07.027.Cel l. 2018.PMID: 30096312
74.
Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial.
Hisamatsu T, Kunisaki R, Nakamura S, Tsujikawa T, Hirai F, Nakase H, Watanabe K, Yokoyama K, Nagahori M, Kanai T, Naganuma M, Michimae H, Andoh A, Yamada A, Yokoyama T, Kamata N, Tanaka S, Suzuki Y, Hibi T, Watanabe M; CERISIER Trial group.Hisamatsu T, et al.Intest Res. 2018 Jul;16(3):494-498. doi: 10.5217/ir.2018.16.3.494. Epub 2018 Jul 27.Intest Res. 2018.PMID: 30090050Free PMC article.No abstract available.
75.
β-(1,3)-Glucan derived from Candida albicans induces inflammatory cytokines from macrophages and lamina propria mononuclear cells derived from patients with Crohn's disease.
Mori K, Naganuma M, Mizuno S, Suzuki H, Kitazume MT, Shimamura K, Chiba S, Sugita A, Matsuoka K, Hisamatsu T, Kanai T.Mori K, et al.Intest Res. 2018 Jul;16(3):384-392. doi: 10.5217/ir.2018.16.3.384. Epub 2018 Jul 27.Intest Res. 2018.PMID: 30090037Free PMC article.
76.
Absence of high-risk stigmata predicts good prognosis even in severely anemic patients with suspected acute upper gastrointestinal bleeding.
Horibe M, Ogura Y, Matsuzaki J, Kaneko T, Yokota T, Okawa O, Nakatani Y, Iwasaki E, Nishizawa T, Hosoe N, Masaoka T, Yahagi N, Namiki S, Kanai T.Horibe M, et al.United European Gastroenterol J. 2018 Jun;6(5):684-690. doi: 10.1177/2050640618764161. Epub 2018 Apr 10.United European Gastroenterol J. 2018.PMID: 30083330Free PMC article.
77.
Clinical utility of novel ultrathin single-balloon enteroscopy: a feasibility study.
Takabayashi K, Hosoe N, Miyanaga R, Fukuhara S, Kimura K, Mizuno S, Naganuma M, Yahagi N, Ogata H, Kanai T.Takabayashi K, et al.Endoscopy. 2019 May;51(5):468-471. doi: 10.1055/a-0656-5622. Epub 2018 Aug 1.Endoscopy. 2019.PMID: 30068003
78.
Reply.
Kanai T, Naganuma M.Kanai T, et al.Gastroenterology. 2018 Aug;155(2):578-579. doi: 10.1053/j.gastro.2018.07.002. Epub 2018 Jul 6.Gastroenterology. 2018.PMID: 30064722No abstract available.
79.
Clinical impact of closure of the mucosal defect after duodenal endoscopic submucosal dissection.
Kato M, Ochiai Y, Fukuhara S, Maehata T, Sasaki M, Kiguchi Y, Akimoto T, Fujimoto A, Nakayama A, Kanai T, Yahagi N.Kato M, et al.Gastrointest Endosc. 2019 Jan;89(1):87-93. doi: 10.1016/j.gie.2018.07.026. Epub 2018 Jul 25.Gastrointest Endosc. 2019.PMID: 30055156Clinical Trial.
80.
[Immune Checkpoint Induced Colitis].
Sukawa Y, Hamamoto Y, Kanai T.Sukawa Y, et al.Gan To Kagaku Ryoho. 2018 Jul;45(7):1027-1030.Gan To Kagaku Ryoho. 2018.PMID: 30042265Japanese.
81.
Pancreatic Fat Content Detected by Computed Tomography and Its Significant Relationship With Intraductal Papillary Mucinous Neoplasm.
Kashiwagi K, Seino T, Fukuhara S, Minami K, Horibe M, Iwasaki E, Takaishi H, Itoh K, Sugino Y, Inoue N, Iwao Y, Kanai T.Kashiwagi K, et al.Pancreas. 2018 Oct;47(9):1087-1092. doi: 10.1097/MPA.0000000000001103.P ancreas. 2018.PMID: 30028443
82.
Successful EUS-guided nondilated pancreatic duct stent placement in patient with refractory pancreatic fistula after pancreaticoduodenectomy.
Minami K, Iwasaki E, Itoi T, Hibi T, Kanai T.Minami K, et al.VideoGIE. 2017 Oct 12;2(11):315-316. doi: 10.1016/j.vgie.2017.07.012. eCollection 2017 Nov.VideoGIE. 2017.PMID: 30027134Free PMC article.No abstract available.
83.
[Review of the small intestinal mucosal lesion].
Hosoe N, Ogata H, Kanai T.Hosoe N, et al.Nihon Shokakibyo Gakkai Zasshi. 2018;115(7):605-611. doi: 10.11405/nisshoshi.115.605.Nih on Shokakibyo Gakkai Zasshi. 2018.PMID: 29998983Review.Japanese.No abstract available.
84.
Idiopathic Thrombocytopenic Purpura Responsive to Surgery for Crohn's Disease.
Mizuno S, Naganuma M, Kanai T.Mizuno S, et al.Inflamm Bowel Dis. 2019 Feb 21;25(3):e26. doi: 10.1093/ibd/izy233.Inflamm Bowel Dis. 2019.PMID: 29961815No abstract available.
85.
Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells.
Murakami Y, Sugiyama K, Ebinuma H, Nakamoto N, Ojiro K, Chu PS, Taniki N, Saito Y, Teratani T, Koda Y, Suzuki T, Saito K, Fukasawa M, Ikeda M, Kato N, Kanai T, Saito H.Murakami Y, et al.BMC Cancer. 2018 Jun 25;18(1):680. doi: 10.1186/s12885-018-4588-y.BMC Cancer. 2018.PMID: 29940898Free PMC article.
86.
Intestinal barrier regulates immune responses in the liver via IL-10-producing macrophages.
Taniki N, Nakamoto N, Chu PS, Mikami Y, Amiya T, Teratani T, Suzuki T, Tsukimi T, Fukuda S, Yamaguchi A, Shiba S, Miyake R, Katayama T, Ebinuma H, Kanai T.Taniki N, et al.JCI Insight. 2018 Jun 21;3(12):e91980. doi: 10.1172/jci.insight.91980. eCollection 2018 Jun 21.JCI Insight. 2018.PMID: 29925685Free PMC article.
87.
Safety and efficacy of ultra-tapered mechanical dilator for EUS-guided hepaticogastrostomy and pancreatic duct drainage compared with electrocautery dilator (with video).
Honjo M, Itoi T, Tsuchiya T, Tanaka R, Tonozuka R, Mukai S, Sofuni A, Nagakawa Y, Iwasaki H, Kanai T.Honjo M, et al.Endosc Ultrasound. 2018 Nov-Dec;7(6):376-382. doi: 10.4103/eus.eus_2_18.Endosc Ultrasound. 2018.PMID: 29882518Free PMC article.
88.
Establishment of a Novel Scoring System for Colon Capsule Endoscopy to Assess the Severity of Ulcerative Colitis-Capsule Scoring of Ulcerative Colitis.
Hosoe N, Nakano M, Takeuchi K, Endo Y, Matsuoka K, Abe T, Omori T, Hayashida M, Kobayashi T, Yoshida A, Mizuno S, Nakazato Y, Naganuma M, Kanai T, Watanabe M, Ueno F, Suzuki Y, Hibi T, Ogata H.Hosoe N, et al.Inflamm Bowel Dis. 2018 Nov 29;24(12):2641-2647. doi: 10.1093/ibd/izy193.Inflamm Bowel Dis. 2018.PMID: 29846579Clinical Trial.
89.
Burden of impaired sleep quality on work productivity in functional dyspepsia.
Matsuzaki J, Suzuki H, Togawa K, Yamane T, Mori H, Komori T, Masaoka T, Kanai T.Matsuzaki J, et al.United European Gastroenterol J. 2018 Apr;6(3):398-406. doi: 10.1177/2050640617726466. Epub 2017 Aug 7.United European Gastroenterol J. 2018.PMID: 29774153Free PMC article.
90.
Acquisition of double mutation in gyrA caused high resistance to sitafloxacin in Helicobacter pylori after unsuccessful eradication with sitafloxacin-containing regimens.
Mori H, Suzuki H, Matsuzaki J, Masaoka T, Kanai T.Mori H, et al.United European Gastroenterol J. 2018 Apr;6(3):391-397. doi: 10.1177/2050640617737215. Epub 2017 Oct 8.United European Gastroenterol J. 2018.PMID: 29774152Free PMC article.
91.
[Future perspectives on fecal microbiota transplantation].
Mizuno S, Nanki K, Kanai T.Mizuno S, et al.Nihon Shokakibyo Gakkai Zasshi. 2018;115(5):449-459. doi: 10.11405/nisshoshi.115.449.Nih on Shokakibyo Gakkai Zasshi. 2018.PMID: 29743453Japanese.No abstract available.
92.
Large Volume Fluid Resuscitation for Severe Acute Pancreatitis is Associated With Reduced Mortality: A Multicenter Retrospective Study.
Yamashita T, Horibe M, Sanui M, Sasaki M, Sawano H, Goto T, Ikeura T, Hamada T, Oda T, Yasuda H, Ogura Y, Miyazaki D, Hirose K, Kitamura K, Chiba N, Ozaki T, Koinuma T, Oshima T, Yamamoto T, Hirota M, Masuda Y, Tokuhira N, Kobayashi M, Saito S, Izai J, Lefor AK, Iwasaki E, Kanai T, Mayumi T.Yamashita T, et al.J Clin Gastroenterol. 2019 May/Jun;53(5):385-391. doi: 10.1097/MCG.0000000000001046.J Clin Gastroenterol. 2019.PMID: 29688917
93.
The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study.
Kurokawa S, Kishimoto T, Mizuno S, Masaoka T, Naganuma M, Liang KC, Kitazawa M, Nakashima M, Shindo C, Suda W, Hattori M, Kanai T, Mimura M.Kurokawa S, et al.J Affect Disord. 2018 Aug 1;235:506-512. doi: 10.1016/j.jad.2018.04.038. Epub 2018 Apr 12.J Affect Disord. 2018.PMID: 29684865
94.
Initial Management of Colonic Diverticular Bleeding: Observational Study.
Wada M, Kato M, Hirai Y, Kubosawa Y, Sunata Y, Abe K, Hirata T, Takada Y, Banno S, Takatori Y, Kinoshita S, Mori H, Takabayashi K, Kikuchi M, Kikuchi M, Suzuki M, Kanai T, Uraoka T.Wada M, et al.Digestion. 2018;98(1):41-47. doi: 10.1159/000487264. Epub 2018 Apr 19.Digestion. 2018.PMID: 29672291Clinical Trial.
95.
Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia.
Namkoong H, Ishii M, Fujii H, Yagi K, Asami T, Asakura T, Suzuki S, Hegab AE, Kamata H, Tasaka S, Atarashi K, Nakamoto N, Iwata S, Honda K, Kanai T, Hasegawa N, Koyasu S, Betsuyaku T.Namkoong H, et al.PLoS Pathog. 2018 Apr 5;14(4):e1006955. doi: 10.1371/journal.ppat.1006955. eCollection 2018 Apr.PLoS Pathog. 2018.PMID: 29621339Free PMC article.
96.
Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously treated with gemcitabine: a meta-analysis.
Kasuga A, Hamamoto Y, Takeuchi A, Okano N, Togasaki K, Aoki Y, Suzuki T, Kawasaki K, Hirata K, Sukawa Y, Kanai T, Takaishi H.Kasuga A, et al.Invest New Drugs. 2018 Oct;36(5):939-948. doi: 10.1007/s10637-018-0589-6. Epub 2018 Mar 23.Invest New Drugs. 2018.PMID: 29572783
97.
Aortic carboxypeptidase-like protein, a WNT ligand, exacerbates nonalcoholic steatohepatitis.
Teratani T, Tomita K, Suzuki T, Furuhashi H, Irie R, Nishikawa M, Yamamoto J, Hibi T, Miura S, Minamino T, Oike Y, Hokari R, Kanai T.Teratani T, et al.J Clin Invest. 2018 Apr 2;128(4):1581-1596. doi: 10.1172/JCI92863. Epub 2018 Mar 19.J Clin Invest. 2018.PMID: 29553485Free PMC article.
98.
[Treatment strategy for inflammatory bowel disease with a focus on biologicals].
Fukuda T, Naganuma M, Kanai T.Fukuda T, et al.Nihon Shokakibyo Gakkai Zasshi. 2018;115(3):272-282. doi: 10.11405/nisshoshi.115.272.Nih on Shokakibyo Gakkai Zasshi. 2018.PMID: 29526979Japanese.No abstract available.
99.
Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis.
Matsuoka K, Uemura Y, Kanai T, Kunisaki R, Suzuki Y, Yokoyama K, Yoshimura N, Hibi T.Matsuoka K, et al.Dig Dis Sci. 2018 Jul;63(7):1910-1919. doi: 10.1007/s10620-018-4946-2. Epub 2018 Feb 15.Dig Dis Sci. 2018.PMID: 29450747Free PMC article.Clinical Trial.
100.
Complications and outcomes of routine endoscopy in the very elderly.
Miyanaga R, Hosoe N, Naganuma M, Hirata K, Fukuhara S, Nakazato Y, Ojiro K, Iwasaki E, Yahagi N, Ogata H, Kanai T.Miyanaga R, et al.Endosc Int Open. 2018 Feb;6(2):E224-E229. doi: 10.1055/s-0043-120569. Epub 2018 Feb 7.Endosc Int Open. 2018.PMID: 29423432Free PMC article.
101.
Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis.
Nanki K, Mizuno S, Matsuoka K, Ono K, Sugimoto S, Kiyohara H, Arai M, Nakashima M, Takeshita K, Saigusa K, Senoh M, Fukuda T, Naganuma M, Kato H, Suda W, Hattori M, Kanai T.Nanki K, et al.Intest Res. 2018 Jan;16(1):142-146. doi: 10.5217/ir.2018.16.1.142. Epub 2018 Jan 18.Intest Res. 2018.PMID: 29422809Free PMC article.
102.
Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in active mesenteric panniculitis patients: A case report.
Mizuno S, Wakui M, Machida Y, Hosoe N, Hisamatsu T, Ishida T, Kameyama K, Naganuma M, Kanai T.Mizuno S, et al.Medicine (Baltimore). 2017 Dec;96(51):e9237. doi: 10.1097/MD.0000000000009237.Me dicine (Baltimore). 2017.PMID: 29390478Free PMC article.Review.
103.
[Intestinal immune response is regulated by gut microbe].
Tanemoto S, Sujino T, Kanai T.Tanemoto S, et al.Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(6):408-415. doi: 10.2177/jsci.40.408.Nihon Rinsho Meneki Gakkai Kaishi. 2017.PMID: 29367525Review.Japanese.
104.
Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression.
Seino T, Kawasaki S, Shimokawa M, Tamagawa H, Toshimitsu K, Fujii M, Ohta Y, Matano M, Nanki K, Kawasaki K, Takahashi S, Sugimoto S, Iwasaki E, Takagi J, Itoi T, Kitago M, Kitagawa Y, Kanai T, Sato T.Seino T, et al.Cell Stem Cell. 2018 Mar 1;22(3):454-467.e6. doi: 10.1016/j.stem.2017.12.009. Epub 2018 Jan 11.Cell Stem Cell. 2018.PMID: 29337182
105.
Reconstruction of the Human Colon Epithelium In Vivo.
Sugimoto S, Ohta Y, Fujii M, Matano M, Shimokawa M, Nanki K, Date S, Nishikori S, Nakazato Y, Nakamura T, Kanai T, Sato T.Sugimoto S, et al.Cell Stem Cell. 2018 Feb 1;22(2):171-176.e5. doi: 10.1016/j.stem.2017.11.012. Epub 2017 Dec 28.Cell Stem Cell. 2018.PMID: 29290616
106.
The impact of visceral adipose tissue as best predictor for difficult colonoscopy and the clinical utility of a long small-caliber scope as rescue.
Kashiwagi K, Inoue N, Yoshida T, Bessho R, Yoneno K, Imaeda H, Ogata H, Kanai T, Sugino Y, Iwao Y.Kashiwagi K, et al.PLoS One. 2017 Dec 21;12(12):e0189817. doi: 10.1371/journal.pone.0189817. eCollection 2017.PLoS One. 2017.PMID: 29267320Free PMC article.
107.
Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis.
Yamada S, Kamada N, Amiya T, Nakamoto N, Nakaoka T, Kimura M, Saito Y, Ejima C, Kanai T, Saito H.Yamada S, et al.BMC Gastroenterol. 2017 Nov 29;17(1):136. doi: 10.1186/s12876-017-0689-3.BMC Gastroenterol. 2017.PMID: 29187142Free PMC article.
108.
Reply to Gheorghe et al.
Naganuma M, Hosoe N, Nakazato Y, Ogata H, Kanai T.Naganuma M, et al.Endoscopy. 2017 Dec;49(12):1286. doi: 10.1055/s-0043-120443. Epub 2017 Nov 29.Endoscopy. 2017.PMID: 29186738No abstract available.
109.
Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.
Naganuma M, Sugimoto S, Mitsuyama K, Kobayashi T, Yoshimura N, Ohi H, Tanaka S, Andoh A, Ohmiya N, Saigusa K, Yamamoto T, Morohoshi Y, Ichikawa H, Matsuoka K, Hisamatsu T, Watanabe K, Mizuno S, Suda W, Hattori M, Fukuda S, Hirayama A, Abe T, Watanabe M, Hibi T, Suzuki Y, Kanai T; INDIGO Study Group.Naganuma M, et al.Gastroenterology. 2018 Mar;154(4):935-947. doi: 10.1053/j.gastro.2017.11.024. Epub 2017 Nov 22.Gastroenterology. 2018.PMID: 29174928Clinical Trial.
110.
Dexmedetomidine vs propofol for gastrointestinal endoscopy: A meta-analysis.
Nishizawa T, Suzuki H, Hosoe N, Ogata H, Kanai T, Yahagi N.Nishizawa T, et al.United European Gastroenterol J. 2017 Nov;5(7):1037-1045. doi: 10.1177/2050640616688140. Epub 2017 Jan 12.United European Gastroenterol J. 2017.PMID: 29163971Free PMC article.Review.
111.
Endoscopic string clip suturing method: a prospective pilot study (with video).
Nishizawa T, Akimoto T, Uraoka T, Mitsunaga Y, Maehata T, Ochiai Y, Fujimoto A, Goto O, Kanai T, Yahagi N.Nishizawa T, et al.Gastrointest Endosc. 2018 Apr;87(4):1074-1078. doi: 10.1016/j.gie.2017.11.007. Epub 2017 Nov 15.Gastrointest Endosc. 2018.PMID: 29154910
112.
The role of colorectal endoscopic submucosal dissection in patients with ulcerative colitis.
Kinoshita S, Uraoka T, Nishizawa T, Naganuma M, Iwao Y, Ochiai Y, Fujimoto A, Goto O, Shimoda M, Ogata H, Kanai T, Yahagi N.Kinoshita S, et al.Gastrointest Endosc. 2018 Apr;87(4):1079-1084. doi: 10.1016/j.gie.2017.10.035. Epub 2017 Nov 6.Gastrointest Endosc. 2018.PMID: 29122603
113.
The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registry.
Fukuda T, Naganuma M, Sugimoto S, Nanki K, Mizuno S, Mutaguchi M, Nakazato Y, Inoue N, Ogata H, Iwao Y, Kanai T.Fukuda T, et al.PLoS One. 2017 Nov 6;12(11):e0187737. doi: 10.1371/journal.pone.0187737. eCollection 2017.PLoS One. 2017.PMID: 29108025Free PMC article.
114.
Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn's Disease.
Watanabe K, Matsumoto T, Hisamatsu T, Nakase H, Motoya S, Yoshimura N, Ishida T, Kato S, Nakagawa T, Esaki M, Nagahori M, Matsui T, Naito Y, Kanai T, Suzuki Y, Nojima M, Watanabe M, Hibi T; DIAMOND study group.Watanabe K, et al.Clin Gastroenterol Hepatol. 2018 Apr;16(4):542-549.e1. doi: 10.1016/j.cgh.2017.10.036. Epub 2017 Nov 11.Clin Gastroenterol Hepatol. 2018.PMID: 29104132Clinical Trial.
115.
Enteric Glial Dysfunction Evoked by Apolipoprotein E Deficiency Contributes to Delayed Gastric Emptying.
Fukuhara S, Masaoka T, Nishimura S, Nakamura M, Matsuzaki J, Tsugawa H, Miyoshi S, Mori H, Kawase S, Shibata S, Okano H, Kanai T, Suzuki H.Fukuhara S, et al.Dig Dis Sci. 2017 Dec;62(12):3359-3369. doi: 10.1007/s10620-017-4820-7. Epub 2017 Nov 2.Dig Dis Sci. 2017.PMID: 29098550
116.
Commensal Lactobacillus Controls Immune Tolerance during Acute Liver Injury in Mice.
Nakamoto N, Amiya T, Aoki R, Taniki N, Koda Y, Miyamoto K, Teratani T, Suzuki T, Chiba S, Chu PS, Hayashi A, Yamaguchi A, Shiba S, Miyake R, Katayama T, Suda W, Mikami Y, Kamada N, Ebinuma H, Saito H, Hattori M, Kanai T.Nakamoto N, et al.Cell Rep. 2017 Oct 31;21(5):1215-1226. doi: 10.1016/j.celrep.2017.10.022.C ell Rep. 2017.PMID: 29091761
117.
Detection of bacterial DNA by in situ hybridization in patients with decompensated liver cirrhosis.
Usui S, Ebinuma H, Chu PS, Nakamoto N, Yamagishi Y, Saito H, Kanai T.Usui S, et al.BMC Gastroenterol. 2017 Oct 17;17(1):106. doi: 10.1186/s12876-017-0664-z.BMC Gastroenterol. 2017.PMID: 29041907Free PMC article.
118.
Effect of prophylactic clipping in colorectal endoscopic resection: A meta-analysis of randomized controlled studies.
Nishizawa T, Suzuki H, Goto O, Ogata H, Kanai T, Yahagi N.Nishizawa T, et al.United European Gastroenterol J. 2017 Oct;5(6):859-867. doi: 10.1177/2050640616687837. Epub 2017 Jan 11.United European Gastroenterol J. 2017.PMID: 29026600Free PMC article.Review.
119.
Antibiotic resistance and gyrA mutation affect the efficacy of 10-day sitafloxacin-metronidazole- esomeprazole therapy for Helicobacter pylori in penicillin allergic patients.
Mori H, Suzuki H, Matsuzaki J, Masaoka T, Kanai T.Mori H, et al.United European Gastroenterol J. 2017 Oct;5(6):796-804. doi: 10.1177/2050640616688995. Epub 2017 Jan 19.United European Gastroenterol J. 2017.PMID: 29026593Free PMC article.
120.
Changes in the Clinical Features and Long-term Outcomes of Colonic Diverticulitis in Japanese Patients.
Mizuki A, Tatemichi M, Nakazawa A, Tsukada N, Nagata H, Kanai T.Mizuki A, et al.Intern Med. 2017 Nov 15;56(22):2971-2977. doi: 10.2169/internalmedicine.7710- 16. Epub 2017 Oct 11.Intern Med. 2017.PMID: 29021428Free PMC article.
121.
Inter-evaluator heterogeneity of clinical diagnosis for locally advanced esophageal squamous cell carcinoma.
Hamamoto Y, Nojima M, Aoki Y, Suzuki T, Kawasaki K, Hirata K, Sukawa Y, Kasuga A, Kawakubo H, Takeuchi H, Murakami K, Takaishi H, Kanai T, Kitagawa Y.Hamamoto Y, et al.Esophagus. 2017;14(4):324-332. doi: 10.1007/s10388-017-0580-x. Epub 2017 May 23.Esophagus. 2017.PMID: 28983229Free PMC article.
122.
Curative resectability of gastrointestinal cancer identified from iron deficiency anemia.
Kawasaki K, Hamamoto Y, Horibe M, Shimura K, Nakamura A, Kanai T, Takaishi H.Kawasaki K, et al.Oncol Lett. 2017 Oct;14(4):4301-4304. doi: 10.3892/ol.2017.6650. Epub 2017 Jul 21.Oncol Lett. 2017.PMID: 28943943Free PMC article.
123.
Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report.
Kawasaki K, Hamamoto Y, Suzuki T, Hirata K, Sukawa Y, Kasuga A, Hayashi Y, Takaishi H, Kameyama K, Kanai T.Kawasaki K, et al.Oncol Lett. 2017 Sep;14(3):3697-3700. doi: 10.3892/ol.2017.6601. Epub 2017 Jul 18.Oncol Lett. 2017.PMID: 28927133Free PMC article.
124.
Intestinal Dysbiosis and Biotin Deprivation Induce Alopecia through Overgrowth of Lactobacillus murinus in Mice.
Hayashi A, Mikami Y, Miyamoto K, Kamada N, Sato T, Mizuno S, Naganuma M, Teratani T, Aoki R, Fukuda S, Suda W, Hattori M, Amagai M, Ohyama M, Kanai T.Hayashi A, et al.Cell Rep. 2017 Aug 15;20(7):1513-1524. doi: 10.1016/j.celrep.2017.07.057.C ell Rep. 2017.PMID: 28813664
125.
The Prognosis of Severe Acute Pancreatitis Varies According to the Segment Presenting With Low Enhanced Pancreatic Parenchyma on Early Contrast-Enhanced Computed Tomography: A Multicenter Cohort Study.
Kitamura K, Horibe M, Sanui M, Sasaki M, Yamamiya A, Ishii Y, Yoshida H, Sawano H, Goto T, Ikeura T, Hamada T, Oda T, Yasuda H, Ogura Y, Miyazaki D, Hirose K, Chiba N, Ozaki T, Yamashita T, Koinuma T, Oshima T, Yamamoto T, Hirota M, Azumi Y, Nagata K, Saito N, Sato M, Miyamoto K, Iwasaki E, Kanai T, Mayumi T.Kitamura K, et al.Pancreas. 2017 Aug;46(7):867-873. doi: 10.1097/MPA.0000000000000851.P ancreas. 2017.PMID: 28697125Clinical Trial.
126.
Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
Mizuno S, Masaoka T, Naganuma M, Kishimoto T, Kitazawa M, Kurokawa S, Nakashima M, Takeshita K, Suda W, Mimura M, Hattori M, Kanai T.Mizuno S, et al.Digestion. 2017;96(1):29-38. doi: 10.1159/000471919. Epub 2017 Jun 21.Digestion. 2017.PMID: 28628918Free PMC article.Clinical Trial.
127.
On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C.
Chu PS, Nakamoto N, Taniki N, Ojiro K, Amiya T, Makita Y, Murata H, Yamaguchi A, Shiba S, Miyake R, Katayama T, Ugamura A, Ikura A, Takeda K, Ebinuma H, Saito H, Kanai T.Chu PS, et al.PLoS One. 2017 Jun 15;12(6):e0179096. doi: 10.1371/journal.pone.0179096. eCollection 2017.PLoS One. 2017.PMID: 28617830Free PMC article.Clinical Trial.
128.
Neural differentiation of human embryonic stem cells induced by the transgene-mediated overexpression of single transcription factors.
Matsushita M, Nakatake Y, Arai I, Ibata K, Kohda K, Goparaju SK, Murakami M, Sakota M, Chikazawa-Nohtomi N, Ko SBH, Kanai T, Yuzaki M, Ko MSH.Matsushita M, et al.Biochem Biophys Res Commun. 2017 Aug 19;490(2):296-301. doi: 10.1016/j.bbrc.2017.06.039. Epub 2017 Jun 10.Biochem Biophys Res Commun. 2017.PMID: 28610919
129.
Effects of patient age and choice of antisecretory agent on success of eradication therapy for Helicobacter pylori infection.
Nishizawa T, Suzuki H, Fujimoto A, Kinoshita H, Yoshida S, Isomura Y, Toyoshima A, Kanai T, Yahagi N, Toyoshima O.Nishizawa T, et al.J Clin Biochem Nutr. 2017 May;60(3):208-210. doi: 10.3164/jcbn.16-86. Epub 2017 Feb 16.J Clin Biochem Nutr. 2017.PMID: 28584402Free PMC article.
130.
Limited Identification of Dual-time-point Positron Emission Tomography/Computed Tomography in Advanced Colorectal Neoplasms.
Kashiwagi K, Nakazato Y, Arai M, Iwasaki E, Naganuma M, Inoue N, Iwao Y, Ogata H, Murakami K, Kanai T.Kashiwagi K, et al.Intern Med. 2017;56(11):1287-1292. doi: 10.2169/internalmedicine.56. 8037. Epub 2017 Jun 1.Intern Med. 2017.PMID: 28566588Free PMC article.
131.
Free cholesterol accumulation in liver sinusoidal endothelial cells exacerbates acetaminophen hepatotoxicity via TLR9 signaling.
Teratani T, Tomita K, Suzuki T, Furuhashi H, Irie R, Hida S, Okada Y, Kurihara C, Ebinuma H, Nakamoto N, Saito H, Hibi T, Miura S, Hokari R, Kanai T.Teratani T, et al.J Hepatol. 2017 Oct;67(4):780-790. doi: 10.1016/j.jhep.2017.05.020. Epub 2017 May 26.J Hepatol. 2017.PMID: 28554874
132.
Colonic dysmotility and morphological abnormality frequently detected in Japanese patients with irritable bowel syndrome.
Mizukami T, Sugimoto S, Masaoka T, Suzuki H, Kanai T.Mizukami T, et al.Intest Res. 2017 Apr;15(2):236-243. doi: 10.5217/ir.2017.15.2.236. Epub 2017 Apr 27.Intest Res. 2017.PMID: 28522955Free PMC article.
133.
Validation of the efficacy of the prognostic factor score in the Japanese severity criteria for severe acute pancreatitis: A large multicenter study.
Ikeura T, Horibe M, Sanui M, Sasaki M, Kuwagata Y, Nishi K, Kariya S, Sawano H, Goto T, Hamada T, Oda T, Yasuda H, Ogura Y, Miyazaki D, Hirose K, Kitamura K, Chiba N, Ozaki T, Yamashita T, Koinuma T, Oshima T, Yamamoto T, Hirota M, Yamamoto S, Oe K, Ito T, Iwasaki E, Kanai T, Okazaki K, Mayumi T.Ikeura T, et al.United European Gastroenterol J. 2017 Apr;5(3):389-397. doi: 10.1177/2050640616670566. Epub 2016 Sep 27.United European Gastroenterol J. 2017.PMID: 28507751Free PMC article.
134.
Endocytoscopy can be used to assess histological healing in ulcerative colitis.
Nakazato Y, Naganuma M, Sugimoto S, Bessho R, Arai M, Kiyohara H, Ono K, Nanki K, Mutaguchi M, Mizuno S, Kobayashi T, Hosoe N, Shimoda M, Abe T, Inoue N, Ogata H, Iwao Y, Kanai T.Nakazato Y, et al.Endoscopy. 2017 Jun;49(6):560-563. doi: 10.1055/s-0043-106556. Epub 2017 May 4.Endoscopy. 2017.PMID: 28472831
135.
Timing of oral refeeding in acute pancreatitis: A systematic review and meta-analysis.
Horibe M, Nishizawa T, Suzuki H, Minami K, Yahagi N, Iwasaki E, Kanai T.Horibe M, et al.United European Gastroenterol J. 2016 Dec;4(6):725-732. doi: 10.1177/2050640615612368. Epub 2015 Oct 13.United European Gastroenterol J. 2016.PMID: 28408989Free PMC article.
136.
Family history is an independent risk factor for the progression of gastric atrophy among patients with Helicobacter pylori infection.
Nishizawa T, Suzuki H, Sakitani K, Yamashita H, Yoshida S, Hata K, Kanazawa T, Fujiwara N, Kanai T, Yahagi N, Toyoshima O.Nishizawa T, et al.United European Gastroenterol J. 2017 Feb;5(1):32-36. doi: 10.1177/2050640616642341. Epub 2016 Jun 22.United European Gastroenterol J. 2017.PMID: 28405319Free PMC article.
137.
Visualization and targeting of LGR5+ human colon cancer stem cells.
Shimokawa M, Ohta Y, Nishikori S, Matano M, Takano A, Fujii M, Date S, Sugimoto S, Kanai T, Sato T.Shimokawa M, et al.Nature. 2017 May 11;545(7653):187-192. doi: 10.1038/nature22081. Epub 2017 Mar 29.Nature. 2017.PMID: 28355176
138.
Polyp detection rate in transverse and sigmoid colon significantly increases with longer withdrawal time during screening colonoscopy.
Kashiwagi K, Inoue N, Yoshida T, Bessyo R, Yoneno K, Imaeda H, Ogata H, Kanai T, Sugino Y, Iwao Y.Kashiwagi K, et al.PLoS One. 2017 Mar 22;12(3):e0174155. doi: 10.1371/journal.pone.0174155. eCollection 2017.PLoS One. 2017.PMID: 28328936Free PMC article.
139.
Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients.
Mizuno S, Nanki K, Matsuoka K, Saigusa K, Ono K, Arai M, Sugimoto S, Kiyohara H, Nakashima M, Takeshita K, Naganuma M, Suda W, Hattori M, Kanai T.Mizuno S, et al.Intest Res. 2017 Jan;15(1):68-74. doi: 10.5217/ir.2017.15.1.68. Epub 2017 Jan 31.Intest Res. 2017.PMID: 28239315Free PMC article.
140.
Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemotherapy.
Kasuga A, Hamamoto Y, Takeuchi A, Kawasaki K, Suzuki T, Hirata K, Sukawa Y, Takaishi H, Kanai T.Kasuga A, et al.Cancer Chemother Pharmacol. 2017 Mar;79(3):595-602. doi: 10.1007/s00280-017-3263-3. Epub 2017 Feb 25.Cancer Chemother Pharmacol. 2017.PMID: 28236000Review.
141.
Plasmapheresis therapy has no triglyceride-lowering effect in patients with hypertriglyceridemic pancreatitis.
Miyamoto K, Horibe M, Sanui M, Sasaki M, Sugiyama D, Kato S, Yamashita T, Goto T, Iwasaki E, Shirai K, Oe K, Sawano H, Oda T, Yasuda H, Ogura Y, Hirose K, Kitamura K, Chiba N, Ozaki T, Oshima T, Yamamoto T, Nagata K, Mine T, Saito K, Sekino M, Furuya T, Matsuda N, Hayakawa M, Kanai T, Mayumi T.Miyamoto K, et al.Intensive Care Med. 2017 Jun;43(6):949-951. doi: 10.1007/s00134-017-4722-3. Epub 2017 Feb 23.Intensive Care Med. 2017.PMID: 28233051Clinical Trial.No abstract available.
142.
Soft palatal melanosis, a simple predictor for neoplasia in the upper aerodigestive tract in Japanese alcoholic men.
Hirata K, Yokoyama A, Nakamura R, Omori T, Kawakubo H, Mizukami T, Maruyama K, Kanai T, Yokoyama T.Hirata K, et al.Cancer Sci. 2017 May;108(5):1058-1064. doi: 10.1111/cas.13207. Epub 2017 Apr 24.Cancer Sci. 2017.PMID: 28218985Free PMC article.
143.
Evaluation of the severity of ulcerative colitis using endoscopic dual red imaging targeting deep vessels.
Naganuma M, Yahagi N, Bessho R, Ohno K, Arai M, Mutaguchi M, Mizuno S, Fujimoto A, Uraoka T, Shimoda M, Hosoe N, Ogata H, Kanai T.Naganuma M, et al.Endosc Int Open. 2017 Jan;5(1):E76-E82. doi: 10.1055/s-0042-119393.Endosc Int Open. 2017.PMID: 28180151Free PMC article.
144.
Glycolysis regulates LPS-induced cytokine production in M2 polarized human macrophages.
Chiba S, Hisamatsu T, Suzuki H, Mori K, Kitazume MT, Shimamura K, Mizuno S, Nakamoto N, Matsuoka K, Naganuma M, Kanai T.Chiba S, et al.Immunol Lett. 2017 Mar;183:17-23. doi: 10.1016/j.imlet.2017.01.012. Epub 2017 Jan 24.Immunol Lett. 2017.PMID: 28130076
145.
Association between Increased Gastric Juice Acidity and Sliding Hiatal Hernia Development in Humans.
Kishikawa H, Kimura K, Ito A, Arahata K, Takarabe S, Kaida S, Kanai T, Miura S, Nishida J.Kishikawa H, et al.PLoS One. 2017 Jan 20;12(1):e0170416. doi: 10.1371/journal.pone.0170416. eCollection 2017.PLoS One. 2017.PMID: 28107506Free PMC article.
146.
Gender Difference of Gastric Emptying in Healthy Volunteers and Patients with Functional Dyspepsia.
Mori H, Suzuki H, Matsuzaki J, Taniguchi K, Shimizu T, Yamane T, Masaoka T, Kanai T.Mori H, et al.Digestion. 2017;95(1):72-78. doi: 10.1159/000452359. Epub 2017 Jan 5.Digestion. 2017.PMID: 28052285
147.
Accuracy of biopsy for the preoperative diagnosis of superficial nonampullary duodenal adenocarcinoma.
Kinoshita S, Nishizawa T, Ochiai Y, Uraoka T, Akimoto T, Fujimoto A, Maehata T, Goto O, Kanai T, Yahagi N.Kinoshita S, et al.Gastrointest Endosc. 2017 Aug;86(2):329-332. doi: 10.1016/j.gie.2016.12.007. Epub 2016 Dec 19.Gastrointest Endosc. 2017.PMID: 28003118
148.
Metal stent for refractory post-ES bleeding: Is this the ultimate treatment modality?
Iwasaki E, Itoi T, Kanai T.Iwasaki E, et al.Endosc Int Open. 2016 Dec;4(12):E1265-E1266. doi: 10.1055/s-0042-117633. Epub 2016 Nov 24.Endosc Int Open. 2016.PMID: 27995187Free PMC article.No abstract available.
149.
Continuous Regional Arterial Infusion of Protease Inhibitors Has No Efficacy in the Treatment of Severe Acute Pancreatitis: A Retrospective Multicenter Cohort Study.
Horibe M, Sasaki M, Sanui M, Sugiyama D, Iwasaki E, Yamagishi Y, Sawano H, Goto T, Ikeura T, Hamada T, Oda T, Yasuda H, Shinomiya W, Miyazaki D, Hirose K, Kitamura K, Chiba N, Ozaki T, Yamashita T, Koinuma T, Oshima T, Yamamoto T, Hirota M, Moriya T, Shirai K, Mayumi T, Kanai T.Horibe M, et al.Pancreas. 2017 Apr;46(4):510-517. doi: 10.1097/MPA.0000000000000775.P ancreas. 2017.PMID: 27977624Free PMC article.Clinical Trial.
150.
Characteristics of gastric cancer detected within 1 year after successful eradication of Helicobacter pylori.
Nishizawa T, Suzuki H, Arano T, Yoshida S, Yamashita H, Hata K, Kanai T, Yahagi N, Toyoshima O.Nishizawa T, et al.J Clin Biochem Nutr. 2016 Nov;59(3):226-230. doi: 10.3164/jcbn.16-43. Epub 2016 Aug 24.J Clin Biochem Nutr. 2016.PMID: 27895391Free PMC article.
151.
Endoscopic morphologic features of ulcerative colitis-associated dysplasia classified according to the SCENIC consensus statement.
Sugimoto S, Naganuma M, Iwao Y, Matsuoka K, Shimoda M, Mikami S, Mizuno S, Nakazato Y, Nanki K, Inoue N, Ogata H, Kanai T.Sugimoto S, et al.Gastrointest Endosc. 2017 Mar;85(3):639-646.e2. doi: 10.1016/j.gie.2016.11.013. Epub 2016 Nov 21.Gastrointest Endosc. 2017.PMID: 27884517
152.
A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients.
Takeshita K, Mizuno S, Mikami Y, Sujino T, Saigusa K, Matsuoka K, Naganuma M, Sato T, Takada T, Tsuji H, Kushiro A, Nomoto K, Kanai T.Takeshita K, et al.Inflamm Bowel Dis. 2016 Dec;22(12):2802-2810. doi: 10.1097/MIB.0000000000000972.I nflamm Bowel Dis. 2016.PMID: 27824645
153.
Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis.
Shinzaki S, Matsuoka K, Iijima H, Mizuno S, Serada S, Fujimoto M, Arai N, Koyama N, Morii E, Watanabe M, Hibi T, Kanai T, Takehara T, Naka T.Shinzaki S, et al.J Crohns Colitis. 2017 Jan;11(1):84-91. doi: 10.1093/ecco-jcc/jjw132. Epub 2016 Jul 27.J Crohns Colitis. 2017.PMID: 27466171Free PMC article.
154.
Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized Trial.
Matsumoto T, Motoya S, Watanabe K, Hisamatsu T, Nakase H, Yoshimura N, Ishida T, Kato S, Nakagawa T, Esaki M, Nagahori M, Matsui T, Naito Y, Kanai T, Suzuki Y, Nojima M, Watanabe M, Hibi T; DIAMOND study group.Matsumoto T, et al.J Crohns Colitis. 2016 Nov;10(11):1259-1266. doi: 10.1093/ecco-jcc/jjw152. Epub 2016 Aug 26.J Crohns Colitis. 2016.PMID: 27566367Clinical Trial.
155.
The Ulcerative Colitis Endoscopic Index of Severity is Useful to Predict Medium- to Long-Term Prognosis in Ulcerative Colitis Patients with Clinical Remission.
Arai M, Naganuma M, Sugimoto S, Kiyohara H, Ono K, Mori K, Saigusa K, Nanki K, Mutaguchi M, Mizuno S, Bessho R, Nakazato Y, Hosoe N, Matsuoka K, Inoue N, Ogata H, Iwao Y, Kanai T.Arai M, et al.J Crohns Colitis. 2016 Nov;10(11):1303-1309. doi: 10.1093/ecco-jcc/jjw104. Epub 2016 May 18.J Crohns Colitis. 2016.PMID: 27194529
156.
Bone marrow-derived macrophages distinct from tissue-resident macrophages play a pivotal role in Concanavalin A-induced murine liver injury via CCR9 axis.
Amiya T, Nakamoto N, Chu PS, Teratani T, Nakajima H, Fukuchi Y, Taniki N, Yamaguchi A, Shiba S, Miyake R, Katayama T, Ebinuma H, Kanai T.Amiya T, et al.Sci Rep. 2016 Oct 11;6:35146. doi: 10.1038/srep35146.Sci Rep. 2016.PMID: 27725760Free PMC article.
157.
An Ileal Inflammatory Fibroid Polyp Treated by Endoscopic Resection.
Takeshita K, Kashiwagi K, Ishibashi Y, Kanai T.Takeshita K, et al.Intern Med. 2016;55(19):2901-2902. doi: 10.2169/internalmedicine.55. 7118. Epub 2016 Oct 1.Intern Med. 2016.PMID: 27725558Free PMC article.No abstract available.
158.
Recent trends and future directions for the medical treatment of ulcerative colitis.
Naganuma M, Mizuno S, Nanki K, Sugimoto S, Kanai T.Naganuma M, et al.Clin J Gastroenterol. 2016 Dec;9(6):329-336. doi: 10.1007/s12328-016-0686-z. Epub 2016 Oct 3.Clin J Gastroenterol. 2016.PMID: 27699641Review.
159.
Influence of regular exercise on gastric emptying in healthy men: a pilot study.
Matsuzaki J, Suzuki H, Masaoka T, Tanaka K, Mori H, Kanai T.Matsuzaki J, et al.J Clin Biochem Nutr. 2016 Sep;59(2):130-133. doi: 10.3164/jcbn.16-29. Epub 2016 Jul 16.J Clin Biochem Nutr. 2016.PMID: 27698540Free PMC article.
160.
Findings of ulceration and severe stricture on MRE can predict prognosis of Crohn's disease in patients treated with anti-TNF treatment.
Naganuma M, Okuda S, Hisamatsu T, Matsuoka K, Mori K, Hosoe N, Nakazato Y, Ogata H, Kanai T.Naganuma M, et al.Abdom Radiol (NY). 2017 Jan;42(1):141-151. doi: 10.1007/s00261-016-0878-5.Abdo m Radiol (NY). 2017.PMID: 27549100Clinical Trial.
161.
Evaluation of performance of the Omni mode for detecting video capsule endoscopy images: A multicenter randomized controlled trial.
Hosoe N, Watanabe K, Miyazaki T, Shimatani M, Wakamatsu T, Okazaki K, Esaki M, Matsumoto T, Abe T, Kanai T, Ohtsuka K, Watanabe M, Ikeda K, Tajiri H, Ohmiya N, Nakamura M, Goto H, Tsujikawa T, Ogata H.Hosoe N, et al.Endosc Int Open. 2016 Aug;4(8):E878-82. doi: 10.1055/s-0042-111389. Epub 2016 Aug 8.Endosc Int Open. 2016.PMID: 27540577Free PMC article.
162.
A simple scoring system to assess the need for an endoscopic intervention in suspected upper gastrointestinal bleeding: A prospective cohort study.
Horibe M, Kaneko T, Yokogawa N, Yokota T, Okawa O, Nakatani Y, Ogura Y, Matsuzaki J, Iwasaki E, Hosoe N, Masaoka T, Inadomi JM, Suzuki H, Kanai T, Namiki S.Horibe M, et al.Dig Liver Dis. 2016 Oct;48(10):1180-6. doi: 10.1016/j.dld.2016.07.009. Epub 2016 Jul 18.Dig Liver Dis. 2016.PMID: 27507771
163.
Endoscopic slip-knot clip suturing method: prospective pilot study (with video).
Nishizawa T, Ochiai Y, Uraoka T, Akimoto T, Mitsunaga Y, Goto O, Fujimoto A, Maehata T, Kanai T, Yahagi N.Nishizawa T, et al.Gastrointest Endosc. 2017 Feb;85(2):433-437. doi: 10.1016/j.gie.2016.07.047. Epub 2016 Jul 27.Gastrointest Endosc. 2017.PMID: 27475491
164.
Polyglycolic acid sheet for closure of esophagobronchial fistula in a patient with Behçet's disease.
Kinoshita S, Nishizawa T, Hisamatsu T, Kanai T, Yahagi N.Kinoshita S, et al.Gastrointest Endosc. 2017 May;85(5):1094-1096. doi: 10.1016/j.gie.2016.07.029. Epub 2016 Jul 25.Gastrointest Endosc. 2017.PMID: 27464672No abstract available.
165.
Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study.
Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Nishizawa T, Masaoka T, Kanai T.Mori H, et al.United European Gastroenterol J. 2016 Jun;4(3):380-7. doi: 10.1177/2050640615618043. Epub 2015 Nov 13.United European Gastroenterol J. 2016.PMID: 27403304Free PMC article.
166.
Successful Pancreatic Duct Stent Placement for Recurrent Pancreatitis in a Patient with Polysplenia with Agenesis of the Dorsal Pancreas and Peutz-Jeghers Syndrome.
Kawasaki S, Itoi T, Iwasaki E, Hosoe N, Ogata H, Kanai T.Kawasaki S, et al.Intern Med. 2016;55(13):1743-6. doi: 10.2169/internalmedicine.55. 6128. Epub 2016 Jul 1.Intern Med. 2016.PMID: 27374675
167.
Cross-sectional small intestinal surveillance of maintenance hemodialysis patients using video capsule endoscopy: SCHEMA study.
Hosoe N, Matsukawa S, Kanno Y, Naganuma M, Imaeda H, Ida Y, Tsuchiya Y, Hibi T, Ogata H, Kanai T.Hosoe N, et al.Endosc Int Open. 2016 May;4(5):E589-96. doi: 10.1055/s-0042-105203. Epub 2016 Apr 15.Endosc Int Open. 2016.PMID: 27227120Free PMC article.
168.
A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis.
Fujii M, Shimokawa M, Date S, Takano A, Matano M, Nanki K, Ohta Y, Toshimitsu K, Nakazato Y, Kawasaki K, Uraoka T, Watanabe T, Kanai T, Sato T.Fujii M, et al.Cell Stem Cell. 2016 Jun 2;18(6):827-38. doi: 10.1016/j.stem.2016.04.003. Epub 2016 May 19.Cell Stem Cell. 2016.PMID: 27212702
169.
Glycolytic pathway affects differentiation of human monocytes to regulatory macrophages.
Suzuki H, Hisamatsu T, Chiba S, Mori K, Kitazume MT, Shimamura K, Nakamoto N, Matsuoka K, Ebinuma H, Naganuma M, Kanai T.Suzuki H, et al.Immunol Lett. 2016 Aug;176:18-27. doi: 10.1016/j.imlet.2016.05.009. Epub 2016 May 18.Immunol Lett. 2016.PMID: 27208804
170.
Indole compounds may be promising medicines for ulcerative colitis.
Sugimoto S, Naganuma M, Kanai T.Sugimoto S, et al.J Gastroenterol. 2016 Sep;51(9):853-61. doi: 10.1007/s00535-016-1220-2. Epub 2016 May 9.J Gastroenterol. 2016.PMID: 27160749Review.
171.
Inhibition of DNA Methylation Suppresses Intestinal Tumor Organoids by Inducing an Anti-Viral Response.
Saito Y, Nakaoka T, Sakai K, Muramatsu T, Toshimitsu K, Kimura M, Kanai T, Sato T, Saito H.Saito Y, et al.Sci Rep. 2016 May 4;6:25311. doi: 10.1038/srep25311.Sci Rep. 2016.PMID: 27143627Free PMC article.
172.
Fatal hemorrhage in a patient with advanced soft tissue sarcoma following radiation and pazopanib treatment: A case report.
Kawasaki K, Hamamoto Y, Fukada J, Adachi M, Sasaki H, Takaishi H, Yoshida K, Kanai T.Kawasaki K, et al.Oncol Lett. 2016 Apr;11(4):2408-2410. doi: 10.3892/ol.2016.4246. Epub 2016 Feb 18.Oncol Lett. 2016.PMID: 27073488Free PMC article.
173.
Ulcerative colitis endoscopic index of severity is associated with long-term prognosis in ulcerative colitis patients treated with infliximab.
Saigusa K, Matsuoka K, Sugimoto S, Arai M, Kiyohara H, Takeshita K, Mizuno S, Mori K, Nanki K, Takeshita T, Nakazato Y, Yajima T, Naganuma M, Hisamatsu T, Ogata H, Iwao Y, Kanai T.Saigusa K, et al.Dig Endosc. 2016 Sep;28(6):665-70. doi: 10.1111/den.12655. Epub 2016 Apr 21.Dig Endosc. 2016.PMID: 26997640
174.
Effects of carbon dioxide insufflation in balloon-assisted enteroscopy: A systematic review and meta-analysis.
Nishizawa T, Suzuki H, Fujimoto A, Ochiai Y, Kanai T, Naohisa Y.Nishizawa T, et al.United European Gastroenterol J. 2016 Feb;4(1):11-7. doi: 10.1177/2050640615588024. Epub 2015 Jun 9.United European Gastroenterol J. 2016.PMID: 26966518Free PMC article.
175.
Effects of preoperative proton pump inhibitor administration on bleeding after gastric endoscopic submucosal dissection: A systematic review and meta-analysis.
Nishizawa T, Suzuki H, Akimoto T, Maehata T, Morizane T, Kanai T, Yahagi N.Nishizawa T, et al.United European Gastroenterol J. 2016 Feb;4(1):5-10. doi: 10.1177/2050640615588023. Epub 2015 Jun 9.United European Gastroenterol J. 2016.PMID: 26966517Free PMC article.Review.
176.
Clinical Efficacy and Safety of Oral Qing-Dai in Patients with Ulcerative Colitis: A Single-Center Open-Label Prospective Study.
Sugimoto S, Naganuma M, Kiyohara H, Arai M, Ono K, Mori K, Saigusa K, Nanki K, Takeshita K, Takeshita T, Mutaguchi M, Mizuno S, Bessho R, Nakazato Y, Hisamatsu T, Inoue N, Ogata H, Iwao Y, Kanai T.Sugimoto S, et al.Digestion. 2016;93(3):193-201. doi: 10.1159/000444217. Epub 2016 Mar 10.Digestion. 2016.PMID: 26959688Clinical Trial.
177.
[Up-to-date medical treatment for ulcerative colitis].
Kiyohara H, Mizuno S, Naganuma M, Kanai T.Kiyohara H, et al.Nihon Shokakibyo Gakkai Zasshi. 2016 Mar;113(3):413-23. doi: 10.11405/nisshoshi.113.413.Nih on Shokakibyo Gakkai Zasshi. 2016.PMID: 26947041Japanese.No abstract available.
178.
Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report.
Kawasaki K, Hamamoto Y, Adachi M, Kanai T, Takaishi H.Kawasaki K, et al.Oncol Lett. 2016 Jan;11(1):231-233. doi: 10.3892/ol.2015.3905. Epub 2015 Nov 10.Oncol Lett. 2016.PMID: 26870193Free PMC article.
179.
Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation.
Shinoda M, Ebinuma H, Itano O, Yamagishi Y, Obara H, Kitago M, Nakamoto N, Hibi T, Yagi H, Abe Y, Matsubara K, Chu PS, Wakayama Y, Taniki N, Yamaguchi A, Amemiya R, Miyake R, Mizota T, Kanai T, Kitagawa Y.Shinoda M, et al.Hepatol Res. 2016 Oct;46(11):1118-1128. doi: 10.1111/hepr.12666. Epub 2016 Apr 22.Hepatol Res. 2016.PMID: 26854748
180.
Endoscopic Severity Predicts Long-Term Prognosis in Crohn's Disease Patients with Clinical Remission.
Naganuma M, Hisamatsu T, Matsuoka K, Kiyohara H, Arai M, Sugimoto S, Mori K, Nanki K, Ohno K, Mutaguchi M, Mizuno S, Bessho R, Nakazato Y, Hosoe N, Inoue N, Iwao Y, Ogata H, Kanai T.Naganuma M, et al.Digestion. 2016;93(1):66-71. doi: 10.1159/000441767. Epub 2016 Jan 14.Digestion. 2016.PMID: 26789838
181.
Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies for Helicobacter pylori Strains Containing the gyrA Mutation.
Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Masaoka T, Kanai T.Mori H, et al.Helicobacter. 2016 Aug;21(4):286-94. doi: 10.1111/hel.12286. Epub 2015 Nov 27.Helicobacter. 2016.PMID: 26612407Clinical Trial.
182.
A novel fully synthetic and self-assembled peptide solution for endoscopic submucosal dissection-induced ulcer in the stomach.
Uraoka T, Ochiai Y, Fujimoto A, Goto O, Kawahara Y, Kobayashi N, Kanai T, Matsuda S, Kitagawa Y, Yahagi N.Uraoka T, et al.Gastrointest Endosc. 2016 Jun;83(6):1259-64. doi: 10.1016/j.gie.2015.11.015. Epub 2015 Dec 1.Gastrointest Endosc. 2016.PMID: 26608126
183.
Endoscopic slipknot clip suturing method: an ex vivo feasibility study (with video).
Nishizawa T, Uraoka T, Sagara S, Suzuki H, Akimoto T, Kanai T, Yahagi N.Nishizawa T, et al.Gastrointest Endosc. 2016 Feb;83(2):447-50. doi: 10.1016/j.gie.2015.09.007. Epub 2015 Sep 21.Gastrointest Endosc. 2016.PMID: 26391734